The return of EO9: A bioreductive indoloquinone targeted at bladder cancer

被引：0
|
作者：
Phillips, RM [1 ]
机构：
[1] Inst Canc Therapeut, Bradford, W Yorkshire, England
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [41] INVITRO ACTIVITY OF THE NOVEL INDOLOQUINONE EO-9 AND THE INFLUENCE OF PH ON CYTOTOXICITY
    PHILLIPS, RM
    HULBERT, PB
    BIBBY, MC
    SLEIGH, NR
    DOUBLE, JA
    BRITISH JOURNAL OF CANCER, 1992, 65 (03) : 359 - 364
  • [42] Development of large-scale synthetic process for antitumor agent EO9
    Kinugawa, M
    Arai, H
    Ogasa, T
    Kasai, M
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1999, 57 (05) : 401 - 406
  • [43] UNUSUALLY MARKED HYPOXIC SENSITIZATION TO INDOLOQUINONE EO9 AND MITOMYCIN-C IN A HUMAN COLON-TUMOR CELL-LINE THAT LACKS DT-DIAPHORASE ACTIVITY
    PLUMB, JA
    WORKMAN, P
    INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (01) : 134 - 139
  • [44] Phase II studies with EO9 in breast, colorectal, gastric, pancreatic and NSCLC
    Wanders, J
    Pavlidis, N
    Gamucci, T
    Huinink, WWT
    Dirix, L
    Wolff, I
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 565 - 565
  • [45] IN-VITRO SCHEDULE-DEPENDENCY OF EO9 AND MILTEFOSINE IN COMPARISON TO STANDARD DRUGS IN COLON-CANCER CELLS
    VANARKOTTE, J
    PETERS, GJ
    PIZAO, PE
    KEEPERS, YPAM
    GIACCONE, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 4 (03) : 709 - 715
  • [46] Purity profile of the indoloquinone anticancer agent EO-9 and chemical stability of EO-9 freeze dried with 2-hydroxypropyl-β-cyclodextrin
    Van der Schoot, S. C.
    Vainchtein, L. D.
    Nuijen, B.
    Gore, A.
    Mirejovsky, D.
    Lenaz, L.
    Beijnen, J. H.
    PHARMAZIE, 2008, 63 (11): : 796 - 805
  • [47] A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9
    G A Choudry
    P A Hamilton Stewart
    J A Double
    M R L Krul
    B Naylor
    G M Flannigan
    T K Shah
    J E Brown
    R M Phillips
    British Journal of Cancer, 2001, 85 : 1137 - 1146
  • [48] A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9
    Choudry, GA
    Stewart, PAH
    Double, JA
    Krul, MRL
    Naylor, B
    Flannigan, GM
    Shah, TK
    Brown, JE
    Phillips, RM
    BRITISH JOURNAL OF CANCER, 2001, 85 (08) : 1137 - 1146
  • [49] ENHANCEMENT OF INTERSTITIAL PHOTODYNAMIC THERAPY BY MITOMYCIN-C AND EO9 IN A MOUSE-TUMOR MODEL
    BAAS, P
    MICHIELSEN, C
    OPPELAAR, H
    VANZANDWIJK, N
    STEWART, FA
    INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (06) : 880 - 885
  • [50] Synthesis and anti-cancer activity of DT-diaphorase activated naphthoquinone pro-drugs and comparison with EO9
    Steans, G
    Loadman, PM
    Maitland, DJ
    Phillips, RM
    BRITISH JOURNAL OF CANCER, 2000, 83 : 70 - 70
12345